According to the research report titled ‘HLA Typing for Transplant Market Size By Technology, By Product and Services, By End-Use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, HLA typing for transplant market is expected to surpass USD 0.8 billion by the year 2025.
 

Advancements in HLA typing along with rising number of transplants for solid organs, stem cells and soft tissues are major factors driving the HLA typing for transplant industry growth. Growing elderly population, increasing disposable income and surging organ demands in Asia-Pacific are further fueling the market expansion.
 

In terms of technology type, molecular assays segment was worth USD 319.7 million in 2018 and is expected to grow substantially during the forecast period. Growing end-user inclination towards efficient and affordable DNA sequencing technologies, surge in demand for high quality DNA sequencers in HLA typing, rapid expansion of NGS in tissue typing and rising adoption of NGS systems in diagnostic laboratories and research centers are aiding the segmental growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/797197/
 

As per product and services scope, reagent & consumables segment is presumed to expand with a CAGR of 11.4 % during 2019-2025. Heavy margins and volumes sales are responsible for generating lucrative revenues.
 

Based on the application spectrum, diagnostics segment generated USD 308.3 million in 2018 and will witness consistent growth throughout the study period. Increased pervasiveness of chronic conditions has impelled the demand for organ transplants. Rising awareness pertaining to organ donations will also stimulate the business scenario.
 

Citing the end-use landscape, HLA typing for transplant market share from hospitals is set to record a CAGR of 11.2% through 2025, primarily due to rising number of diagnostics tests in HLA typing for organ transplant in hospitals. Increasing hospitalizations and amplifying number of transplant procedures are favoring the market outlook.
 

Considering the geographical landscape, the U.S. HLA typing for transplant industry accrued USD 133.5 million in 2018 and is projected to showcase similar growth trends during the estimated timespan.
 

On the other hand, Asia-Pacific market is poised to acquire notable gains by the year 2025, owing to increasing awareness regarding organ transplantation, rising hematopoietic transplantation and growing number of bone marrow donors .
 

The eminent companies operating in HLA typing for transplant industry are Bio-Rad Laboratories, Illumina Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and F. Hoffmann-La Roche Ltd.